Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃

Introduction/Overview

Dehydroepiandrosterone (DHEA) is an endogenous steroid hormone mainly produced by the adrenal cortex and is widely present in the human bloodstream. As the most abundant precursor to steroid hormones in the body, DHEA is not only a precursor to various sex hormones (such as testosterone and estrogen) but also possesses multiple biological functions. In recent years, with the deepening of research in anti-aging medicine and metabolic diseases, DHEA has become a research hotspot in the field of natural product pharmacology due to its potential effects in regulating energy metabolism, antioxidant stress, immune regulation, and neuroprotection. This paper will systematically review the chemical structure and physicochemical properties of DHEA, plant origin and extraction methods, pharmacological activity, and mechanism of action, combined with its druggability evaluation and clinical application prospects, aiming to provide theoretical foundation and practical guidance for related research.

Chemical structure and physicochemical properties

The chemical structure of dehydroepiandrosterone is an androster-5-ene backbone, with positions 3 containing β-hydroxyl groups and position 17 being an oxogroup group, chemical formula C19H28O2, and molecular weight 288.4310. Its structural characteristics make it a 3β-hydroxy-delta(5)-steroid and 17-oxosteroid, and it is also classified as an androsterane compound. DHEA has a LogP value of 3.2703, showing good lipid solubility, which helps penetrate cell membranes and the blood-brain barrier (BBB has high permeability). Its polar surface area (TPSA) is 37.3 Ų, with low water solubility (0.0626 mg/mL), indicating that it mainly exists in the body as a binding protein. DHEA does not show hERG channel inhibitory activity, and Ames-induced mutagenic test results are zero, indicating high safety and promising drug potential.

Plant Origins and Extraction Methods

Although DHEA is mainly synthesized by animal adrenal glands, trace amounts are also present in plants, especially detected in certain medicinal plants and algae. DHEA from natural plant sources is extremely low and difficult to meet large-scale demand, so current industrial production mainly relies on chemical synthesis or obtained from plant sterols (such as wild soy sterol) through semi-synthetic pathways.

In terms of extraction methods, traditional solvent extraction combined with column chromatography can be used to separate DHEA from plant raw materials. Modern technologies such as supercritical CO2 extraction, ultrasound-assisted extraction, and high-performance liquid chromatography (HPLC) purification have improved extraction efficiency and purity. Biosynthetic engineering is gradually becoming an important direction for future DHEA production, achieving efficient conversion from plant sterols to DHEA through genetically engineered microorganisms expressing specific enzyme systems.

Pharmacological activity research

DHEA has multiple pharmacological activities, covering areas such as endocrine regulation, metabolic regulation, neuroprotection, and immune regulation.

1. Anti-aging effects
   DHEA levels significantly decrease with age, and supplementing with DHEA is believed to delay age-related physiological decline. Animal studies have shown that DHEA can improve mitochondrial function, reduce oxidative stress, and extend lifespan. Its anti-aging effects are closely related to the regulation of key age-related targets such as AMPK, SIRT1, and TERT.

2. Metabolic regulation
   DHEA is involved in lipid metabolism and glucose homeostasis, promoting fatty acid oxidation, improving insulin sensitivity, and alleviating symptoms of obesity and type 2 diabetes. It regulates energy metabolism balance by activating the AMPK signaling pathway.

3. Neuroprotection
   DHEA has neuroprotective and cognitive function enhancement effects in the central nervous system. Its high blood-brain barrier permeability allows it to act directly on neurons, reduce neuroinflammation, promote nerve regeneration, and may have potential therapeutic value for neuropsychiatric disorders such as Alzheimer's and depression.

4. Immune regulation
   DHEA regulates immune cell function and enhances the body's ability to fight infections. It can regulate the expression of inflammatory factors, balance pro-inflammatory and anti-inflammatory responses, and help improve autoimmune diseases.

Mechanism of action and molecular targets

The biological effects of DHEA are mainly realized through multiple signaling pathways and molecular targets:

• AMPK (5' AMP-activated protein kinase) :D HEA activates AMPK, promotes energy metabolism and lipid oxidation, and inhibits inflammatory responses.
• SIRT1 (Silencing Information Regulatory Factor 2-Related Enzyme 1): As a deacetylating enzyme, SIRT1 regulates cellular stress responses and lifespan. DHEA improves mitochondrial function and antioxidant capacity by activating SIRT1.
• TERT (telomerase reverse transcriptase) :D HEA promotes TERT expression, delays telomere shortening, and delays cellular aging.
• TP53 (tumor suppressor protein p53) :D HEA regulates the p53-mediated cell cycle and apoptosis, maintaining cellular homeostasis.
• NRF2 (Nuclear Factor 2-related factor 2) :D HEA activates the NRF2 signaling pathway, enhancing the expression of antioxidant enzymes (such as SOD1, CAT, HMOX1) to resist oxidative stress.
• FOXO1 (fork-head box protein O1) :D HEA regulates FOXO1, promoting cellular antioxidant and metabolic homeostasis.
• CDKN1A (a cyclin-dependent kinase inhibitor 1A, p21) :D HEA affects cell cycle regulation and promotes cell repair and survival.

The synergistic effects of these targets form the molecular basis for DHEA's multidimensional regulation, demonstrating its potential as an anti-aging and metabolic regulator.

Druggability evaluation and pharmacokinetics

Druggability evaluation of DHEA indicates it possesses good medicinal properties. It has moderate molecular weight, high lipid solubility, easily penetrates cell membranes, and has good blood-brain barrier permeability, making it suitable for treating central nervous system diseases. Its low water solubility limits oral bioavailability, but it can be significantly improved through formulation optimization (such as nanocarriers and liposomes).

Toxicological evaluation showed that DHEA had no significant hERG channel inhibition, reducing the risk of cardiotoxicity; the Ames test was negative, indicating a low genotoxicity risk. Pharmacokinetic studies show that DHEA is rapidly absorbed orally with a short plasma half-life, mainly metabolized by the liver into active metabolites (such as androgens and estrogens). The metabolic pathway is complex and involves multiple cytochrome P450 enzyme families.

Prospects and outlooks for clinical applications

As an endogenous steroid hormone supplement, DHEA has demonstrated potential efficacy in various clinical trials, especially showing promising prospects in anti-aging, osteoporosis, metabolic syndrome, and neurodegenerative diseases.

1. Anti-aging and health promotion
   DHEA supplementation can improve muscle mass, bone density, and cognitive function in the elderly, reduce inflammatory markers, and delay the onset of age-related diseases.

2. Treatment of metabolic diseases
   For obese and diabetic patients, DHEA can improve insulin sensitivity, regulate lipid metabolism, and assist in controlling blood sugar and body weight.

3. Neuropsychiatric disorders
   DHEA has demonstrated neuroprotective effects in depression, cognitive impairment, and Alzheimer's disease, and is expected to become an adjunct therapy for neurological diseases in the future.

4. Immune regulation
   DHEA can regulate the immune balance of autoimmune diseases, reduce inflammatory responses, and has potential immunotherapy value.

Although the clinical application prospects for DHEA are broad, further large-scale randomized controlled trials are needed to verify its long-term safety and efficacy, optimize administration regimens and formulations, and improve bioavailability.

Conclusion

Dehydroepiandrosterone (DHEA), as an important endogenous steroid hormone, demonstrates broad application potential in anti-aging, metabolic regulation, neuroprotection, and immune regulation due to its multi-target and multi-pathway pharmacological activity. Its excellent druggability and safety lay the foundation for clinical development. In the future, by combining modern drug formulation technologies with precision medicine strategies, DHEA is expected to become an important drug candidate in the field of natural product pharmacology, providing new solutions for healthy aging in humans and the treatment of related diseases. Systematic and in-depth mechanistic research and clinical validation will be key to advancing DHEA toward clinical application.